Trial Profile

Pilot Study of the ReZolve Sirolimus-Eluting Bioresorbable Coronary Stent

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 31 Mar 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sirolimus (Primary)
Indications Coronary artery disease
Focus Therapeutic Use
Acronyms RESTORE
Sponsors REVA Medical

Most Recent Events

27 Mar 2023 Status changed from active, no longer recruiting to completed.
12 Sep 2018 Planned End Date changed from 1 Oct 2018 to 1 Apr 2019.
26 Apr 2017 Planned End Date changed from 1 Sep 2018 to 1 Oct 2018.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com